These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5053672)

  • 1. Potential hypolipidemic agents. I. Syntheses of esters related to 5-fluoro- and 5-chloronicotinic acid and the corresponding alcohols. Effects on noradrenaline-stimulated free fatty acid mobilization.
    Carlson LA; Hedbom C; Helgstrand E; Misiorny A; Sjöberg B; Stjernström NE; Westin G
    Acta Pharm Suec; 1972 Jun; 9(3):221-8. PubMed ID: 5053672
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential hypolipidemic agents. 3. Heterocyclic compounds affecting free fatty acid mobilization in vivo.
    Carlson LA; Hedbom C; Helgstrand E; Sjöberg B; Stjernström NE
    Acta Pharm Suec; 1972 Sep; 9(4):289-304. PubMed ID: 4655344
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential hypolipidemic agents. V. Syntheses of some new 3-substituted pyridines. Effects on noradrenaline-stimulated free fatty acid mobilization.
    Carlson LA; Hedbom C; Misiorny A; Sjöberg B; Stjernström NE; Westin G
    Acta Pharm Suec; 1972 Nov; 9(5):405-10. PubMed ID: 4650117
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential hypolipidemic agents. VI. Syntheses of some new halo-substituted pyridine compounds. Effects on noradrenaline-stimulated free fatty acid mobilization.
    Carlson L; Hedbom C; Helgstrand E; Misiorny A; Sjöberg B; Stjernström NE; Westin G
    Acta Pharm Suec; 1972 Nov; 9(5):411-8. PubMed ID: 4650118
    [No Abstract]   [Full Text] [Related]  

  • 5. Pantetheine and pantethine esters with hypolipidemic nicotinic acid derivatives.
    Picciòla G; Calvi E; Ravenna F; Gentili P; Manzardo S; Riva M
    Arzneimittelforschung; 1985; 35(12):1768-71. PubMed ID: 4096728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arteriosclerosis--nicotinic acid therapy. 12. Some effects on experimental animals].
    Brattsand R; Lindström E
    Lakartidningen; 1971 Apr; 68(15):1776-82. PubMed ID: 4325229
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and hypolipidemic activity of some new esters of glycerol and 2-O-methyl-glycerol with nicotinic and 5-fluoro-nicotinic acids.
    Dall'Asta L; Comini A; Borella F; Berti MA; Coppi G
    Boll Chim Farm; 1989 Mar; 128(3):106-10. PubMed ID: 2775523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of propranolol and nicotinic acid on the inhibition of plasma free fatty acid release in the dog.
    Lipson MJ; Naimi S; Proger S
    Circ Res; 1971 Feb; 28(2):270-6. PubMed ID: 5549068
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of nicotinic acid on the caffeine-induced serum free fatty acid increase.
    Bellet S; Roman LR; Sandberg H; Kostis JB
    J Pharmacol Exp Ther; 1970 Nov; 175(2):348-51. PubMed ID: 5481704
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of nicotinic acid on ACTH and noradrenaline stimulated lipolysis in the rabbit. I. In vivo studies.
    Boberg J; Micheli H; Rammer L
    Acta Physiol Scand; 1970 Jun; 79(2):153-7. PubMed ID: 4318364
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of novel vasodilatory active nicotinate esters with amino acid function.
    Girgis AS; Kalmouch A; Ellithey M
    Bioorg Med Chem; 2006 Dec; 14(24):8488-94. PubMed ID: 16973365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arteriosclerosis--nicotinic acid therapy. 3. Lipolytic effects of nicotinic acid and its derivatives].
    Lundholm L
    Lakartidningen; 1971 Apr; 68(15):1746-9. PubMed ID: 5577245
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of a combination of propranolol and nicotinic acid on the inhibition of norepinephrine-induced elevations of serum triglyceride, serum glycerol, and plasma free fatty acids in the dog.
    Lipson MJ; Naimi S; Proger S
    Metabolism; 1971 Jun; 20(6):580-9. PubMed ID: 5578972
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacology of 5-(3-pyridyl)tetrazole, a hypocholesteremic lipolysis inhibitor.
    Pereira JN; Holland GF; Hochstein FA; Gilgore S; Defelice S; Pinson R
    J Pharmacol Exp Ther; 1968 Jul; 162(1):148-54. PubMed ID: 5690452
    [No Abstract]   [Full Text] [Related]  

  • 15. Lowering of serum lipid levels by "masked" nicotinic acid derivatives.
    Bailey DM; Wood D; Johnson RE; McAuliff JP; Bradford JC; Arnold A
    J Med Chem; 1972 Apr; 15(4):344-8. PubMed ID: 5019547
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of resistance to a potent lipolysis inhibitor, 3-methylisoxazole-5-carboxylic acid.
    Pereira JN; Holland GF
    J Pharmacol Exp Ther; 1967 Aug; 157(2):381-7. PubMed ID: 6039829
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arteriosclerosis--nicotinic acid therapy. 11. Nicotinic acid and tissue triglycerides].
    Fröberg SO
    Lakartidningen; 1971 Apr; 68(15):1773-5. PubMed ID: 5577253
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum free fatty acids level after an experimentally induced emotional stress and its modification by nicotinic acid in rats with different characteristics of higher nervous activity.
    Benes V; Hrubes V
    Act Nerv Super (Praha); 1968; 10(4):395-9. PubMed ID: 5753188
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of nicotinic acid on plasma free fatty acid level and basal energy metabolism in man.
    Doi K; Kuroshima A; Ito S
    Nihon Seirigaku Zasshi; 1969; 31(12):705-6. PubMed ID: 5392802
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myocardial metabolism during long term exercise with low arterial concentration of free fatty acids after nicotinic acid].
    Kaijser L; Carlson LA; Lassers BW; Wahlqvist M
    Nord Med; 1971 Aug; 86(34):1011. PubMed ID: 5099369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.